WELL 📈 WELL Health Technologies - Overview
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA94947L1022
WELL: Healthcare, Software, Telehealth, Electronic, Medical, Records, Cybersecurity
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare. The company also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, it operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); Apps.health, a digital health app marketplace; billing and revenue cycle management solutions for billing and back-office services comprising billing-as-a-service outsourcing services to doctors; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, an EMR platform. The company was founded in 2010 and is headquartered in Vancouver, Canada. Web URL: https://well.company
Additional Sources for WELL Stock
WELL Stock Overview
| Market Cap in USD | 1,018m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
WELL Stock Ratings
| Growth 5y | 49.1% |
| Fundamental | 62.2% |
| Dividend | - |
| Rel. Strength Industry | 3351 |
| Analysts | - |
| Fair Price Momentum | 7.14 CAD |
| Fair Price DCF | 5.93 CAD |
WELL Dividends
No Dividends PaidWELL Growth Ratios
| Growth Correlation 3m | 91.1% |
| Growth Correlation 12m | 77.5% |
| Growth Correlation 5y | -5.5% |
| CAGR 5y | 35.40% |
| CAGR/Mean DD 5y | 0.92 |
| Sharpe Ratio 12m | 1.50 |
| Alpha | 54.97 |
| Beta | 1.07 |
| Volatility | 43.34% |
| Current Volume | 880.2k |
| Average Volume 20d | 1737k |
What is the price of WELL stocks?
As of December 21, 2024, the stock is trading at CAD 7.10 with a total of 880,160 shares traded.
Over the past week, the price has changed by +2.03%, over one month by +39.56%, over three months by +61.38% and over the past year by +80.46%.
As of December 21, 2024, the stock is trading at CAD 7.10 with a total of 880,160 shares traded.
Over the past week, the price has changed by +2.03%, over one month by +39.56%, over three months by +61.38% and over the past year by +80.46%.
Is WELL Health Technologies a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, WELL Health Technologies (TO:WELL) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 62.23 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WELL as of December 2024 is 7.14. This means that WELL is currently overvalued and has a potential downside of 0.56%.
Yes, based on ValueRay Fundamental Analyses, WELL Health Technologies (TO:WELL) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 62.23 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WELL as of December 2024 is 7.14. This means that WELL is currently overvalued and has a potential downside of 0.56%.
Is WELL a buy, sell or hold?
WELL Health Technologies has no consensus analysts rating.
WELL Health Technologies has no consensus analysts rating.
What are the forecast for WELL stock price target?
According to ValueRays Forecast Model, WELL WELL Health Technologies will be worth about 7.9 in December 2025. The stock is currently trading at 7.10. This means that the stock has a potential upside of +10.99%.
According to ValueRays Forecast Model, WELL WELL Health Technologies will be worth about 7.9 in December 2025. The stock is currently trading at 7.10. This means that the stock has a potential upside of +10.99%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 7.7 | 8.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 7.9 | 11% |